Remimazolam to prevent hemodynamic instability during catheter ablation under general anesthesia: a randomized controlled trial

CONCLUSIONS: Remimazolam was a viable option for general anesthesia for cardiac ablation. Remimazolam-based total intravenous anesthesia was associated with significantly fewer hypotensive events and vasopressor requirements than desflurane-based inhalational anesthesia was, without significantly more complications.STUDY REGISTRATION: ClinicalTrials.gov (NCT05486377); first submitted 1 August 2022.PMID:38609684 | DOI:10.1007/s12630-024-02735-z

Source: Canadian Journal of Anaesthesia - April 12, 2024 Category: Anesthesiology Authors: Subin Yim Chang Ik Choi Insun Park Bon Wook Koo Ah Young Oh In-Ae Song Source Type: research